DAVID N GILL Insider Trading
Get free email notifications about insider trading for DAVID N GILL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID N GILL. DAVID N GILL is a Senior Vice President and CFO in CTI MOLECULAR IMAGING INC ($CTMI) and a in STRATA Skin Sciences, Inc. ($MELA) and a Director in STRATA Skin Sciences, Inc. ($MELA) and a Director in HISTOGENICS CORP ($HSGX) and a Director in CEMPRA, INC. ($CEMP) and a Director in Evolus, Inc. ($EOLS) and a Chief Financial Officer in EndoChoice Holdings, Inc. ($GI) and a President and CFO in EndoChoice Holdings, Inc. ($GI) and a Director in Strongbridge Biopharma plc ($SBBP) and a Director in Y-mAbs Therapeutics, Inc. ($YMAB).
Address: 810 INNOVATION DRIVE KNOXVILLE 37932 TN
Companies in which DAVID N GILL is an Insider
CTI MOLECULAR IMAGING INC
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of DAVID N GILL: Senior Vice President and CFO
Holdings: 0 shares
Latest Transaction: May 06 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EndoChoice Holdings, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DAVID N GILL: President and CFO, Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Nov 23 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Evolus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID N GILL: Director
Holdings: 24,313 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MELINTA THERAPEUTICS, INC. /NEW/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID N GILL: Director
Holdings: 6,000 shares
Current Value: $18,000
Latest Transaction: Jun 12 2019
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocugen, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID N GILL: Director
Holdings: 14,000 shares
Current Value: $23,240
Latest Transaction: Jun 19 2018
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STRATA Skin Sciences, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DAVID N GILL:
Holdings: 64,694 shares
Latest Transaction: Nov 26 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Strongbridge Biopharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID N GILL: Director
Holdings: 95,821 shares
Latest Transaction: May 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Y-mAbs Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID N GILL: Director
Holdings: 2,000 shares
Latest Transaction: Jun 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID N GILL
Sentiment: All, CTMI, GI, EOLS, MLNT, HSGX, MELA, SBBP, YMAB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | A | 37.53 | 16,000 | 600,480 | 16,000 | |
| May 18 2021 | SBBP | Strongbridge Bioph ... | GILL DAVID N | Director | Grant | A | 0.00 | 40,000 | 0 | 95,821 | 55.8 K to 95.8 K (+71.66 %) |
| Feb 09 2021 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Grant | A | 0.00 | 19,313 | 0 | 24,313 | 5 K to 24.3 K (+386.26 %) |
| Jan 20 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | M | 11.16 | 2,000 | 22,320 | 24,000 | |
| Jan 20 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Sell | S | 46.52 | 2,000 | 93,045 | 0 | 2 K to 0 (-100.00 %) |
| Jan 20 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Buy | M | 11.16 | 2,000 | 22,320 | 2,000 | 0 to 2 K |
| Nov 20 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | M | 11.16 | 2,000 | 22,320 | 26,000 |